TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026
Long-term survival outcomes from a phase II trial of perioperative capecitabine plus oxaliplatin for advanced gastric cancer with extensive lymph node metastases: OGSG 1701.
Shunji Endo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.